Marialuisa Sponziello
Overview
Explore the profile of Marialuisa Sponziello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Costanzo A, Pirona I, Buonaiuto S, DErasmo L, Bini S, Tramontano D, et al.
J Am Coll Cardiol
. 2024 Oct;
84(18):1767-1770.
PMID: 39365223
No abstract available.
2.
Verrienti A, Pecce V, Grani G, Del Gatto V, Barp S, Maranghi M, et al.
J Endocrinol Invest
. 2024 Sep;
48(3):619-631.
PMID: 39298113
Purpose: Papillary thyroid carcinoma (PTC) is the most common malignant thyroid neoplasm, accounting for approximately 85% of all follicular cell-derived thyroid nodules. This study aimed to assess the diagnostic potential...
3.
Grani G, Sponziello M, Filetti S, Durante C
Nat Rev Endocrinol
. 2024 Aug;
20(12):715-728.
PMID: 39152228
Thyroid nodules, with a prevalence of almost 25% in the general population, are a common occurrence. Their prevalence varies considerably depending on demographics such as age and sex as well...
4.
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells
Maggisano V, Capriglione F, Verrienti A, Celano M, Sponziello M, Pecce V, et al.
Endocrine
. 2022 Dec;
79(3):517-526.
PMID: 36474133
Purpose: In this study, we evaluated the biological role of miRNA-31-5p in papillary thyroid cancer (PTC). Methods: By using the real-time PCR, we measured miRNA-31-5p expression levels in 25 PTC...
5.
Verrienti A, Grani G, Sponziello M, Pecce V, Damante G, Durante C, et al.
Front Oncol
. 2022 Sep;
12:992636.
PMID: 36091144
Aberrant activation of the proto-oncogene is implicated in a plethora of cancers. gain-of-function point mutations are driver events in multiple endocrine neoplasia 2 (MEN2) syndrome and in sporadic medullary thyroid...
6.
Grani G, Ciotti L, Del Gatto V, Montesano T, Biffoni M, Giacomelli L, et al.
Endocrine
. 2022 Jul;
79(1):45-48.
PMID: 35857273
No abstract available.
7.
Grani G, Ciotti L, Del Gatto V, Montesano T, Biffoni M, Giacomelli L, et al.
Endocrine
. 2022 Jul;
78(2):387-391.
PMID: 35802229
No abstract available.
8.
Gentili M, Martini L, Sponziello M, Becchetti L
Bioinformatics
. 2022 Jul;
38(17):4145-4152.
PMID: 35792834
Motivation: Over the past decade, network-based approaches have proven useful in identifying disease modules within the human interactome, often providing insights into key mechanisms and guiding the quest for therapeutic...
9.
Maggisano V, Capriglione F, Verrienti A, Celano M, Gagliardi A, Bulotta S, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625697
The release of molecules in exosomal cargoes is involved in tumor development and progression. We compared the profiles of exosomal microRNAs released by two thyroid cancer cell lines (TPC-1 and...
10.
Pecce V, Sponziello M, Bini S, Grani G, Durante C, Verrienti A
STAR Protoc
. 2022 May;
3(2):101393.
PMID: 35600922
Here, we describe a protocol to generate organoids from human thyroid cancer cells. Starting from the same patient-derived cells, we establish both organoids and primary lines. The organoid medium is...